Evidence map›Paper›PMID 34429622›Full record

ArticleInfection and drug resistance2021

Monika Kabała, Zygmunt Gofron, Małgorzata Aptekorz, Krzysztof Sacha, Celine Harmanus, Ed Kuijper, Gayane Martirosian

Open access · goldAbstract read
In one paragraph

Article in Infection and drug resistance, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Addressing Unmet Needs inCurrent medicinal chemistry · 2026
    Review
  3. Article
  4. Review
  5. Dominance of toxigenicFrontiers in microbiology · 2025
    Article
  6. Article
  7. High Prevalence ofPathogens (Basel, Switzerland) · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Monika Kabała *Department of Medical Microbiology Medical University of Silesia in Katowice, Katowice, Poland.ORCID 0000-0003-4234-586X
Zygmunt Gofron *Department of Medical Microbiology Medical University of Silesia in Katowice, Katowice, Poland.ORCID 0000-0002-3601-1356
Małgorzata AptekorzDepartment of Medical Microbiology Medical University of Silesia in Katowice, Katowice, Poland.ORCID 0000-0002-7343-4702
Krzysztof SachaDepartment of Medical Microbiology Medical University of Silesia in Katowice, Katowice, Poland.ORCID 0000-0001-7591-1253
Celine HarmanusDepartment of Medical Microbiology Leiden University Medical Center, Leiden, the Netherlands.ORCID 0000-0002-5328-3273
Ed KuijperDepartment of Medical Microbiology Leiden University Medical Center, Leiden, the Netherlands.ORCID 0000-0001-5726-2405
Gayane MartirosianDepartment of Medical Microbiology Medical University of Silesia in Katowice, Katowice, Poland.ORCID 0000-0002-0311-0884
Medical University of Silesia · PLLeiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study was MATERIALS AND

methodsTwenty-nine

resultsThe A, B and binary toxins encoding genes were detected in all 29

conclusionMLVA analysis proved transmission and recognized outbreak due to multidrug-resistant RT 027

Indexed as

Clostridioides difficileepidemiologyMLVArifampicin resistanceRT 027

Identifiers

PMID34429622
PMCPMC8380304
OpenAlexW3194725513

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.